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Background: Type 2 diabetes (T2D) decreases health-related quality of life, but there is a lack of information about
the health status of people in pre-diabetic states. However, information on health utility weights (HUWs) for pre-diabetic
states and T2D are essential to estimate the effect of prevention initiatives. We estimated and compared HUWs for
healthy individuals, those with pre-diabetes and those with T2D in a Swedish population and evaluated the influence
of age, sex, education and body mass index on HUWs.
Methods: Participants of the Västerbotten Intervention Program, Sweden, between 2002 and 2012, who underwent an oral
glucose tolerance test or indicated they had T2D and who filled in the Short Form-36 questionnaire (SF-36) were included.
Individuals were categorized as healthy, being in any of three different pre-diabetic states, or as T2D. The pre-diabetic states
are impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or a combination of both (IFG&IGT). The SF-6D index
was used to convert SF-36 responses to HUWs. HUWs were stratified by age, sex, education and body mass index. Beta
regression analyses were conducted to estimate the effect of multiple risk factors on the HUWs.
Results: In total, 55 882 individuals were included in the analysis. The overall mean HUW was 0.764. The mean
HUW of healthy individuals was 0.768, 0.759 for those with IFG, 0.746 for those with IGT, 0.745 for those with
IFG&IGT, and 0.738 for those with T2D. In the overall model, all variables except underweight vs. normal weight
were significantly associated with HUW. Younger age, male sex, and higher education were associated with
increased HUW. Normal weight, or being overweight was associated with elevated HUW, while obesity was
associated with lower HUW.
Conclusions: Healthy individuals had higher HUWs than participants with T2D, while individuals with IFG, IGT or
IFG&IGT had HUWs that ranged between those for NGT and T2D. Therefore, preventing the development of pre-diabetic
states would improve health-related quality of life in addition to lowering the risk of developing T2D.
Keywords: Health utility, Normal glucose tolerance, Impaired fasting glucose, Impaired glucose tolerance, Type 2
diabetes mellitus, Sweden, SF-36, SF-6D, Health-related quality of life, Beta regressionBackground
Type 2 diabetes mellitus (T2D) is a severe disease with
an estimated number of cases exceeding 370 million glo-
bally and 390 000 in Sweden in 2012 [1]. These numbers
are expected to increase to over 550 million and 432 000
by 2030, respectively [1]. Several studies have shown that
prevention of T2D is possible by changing behavior, such* Correspondence: anne.neumann@uniklinikum-dresden.de
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unless otherwise stated.as through physical activity and diet [2-4]. However,
prevention does not start with the onset of the disease,
but needs to address the early stages of T2D. Therefore,
the best scenario involves preventing the development of
pre-diabetic states among healthy individuals.
T2D and pre-diabetic states can be detected using a stan-
dardized oral glucose tolerance test and medical classifica-
tions, such as those of the World Health Organization [5].
According to this classification of blood glucose levels, a
person can be categorized as normal glucose tolerant
(NGT), i.e. healthy, being in a pre-diabetic state, or asral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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glucose (IFG), impaired glucose tolerance (IGT), and a
combination of both (IFG&IGT). Subjects in any of these
three pre-diabetic states have moderate to severe insulin
resistance, impaired insulin secretion and/or insulin sensi-
tivity, and each state has distinct pathophysiologic etiolo-
gies and risks of developing into T2D [6,7].
Disease, such as T2D, is assumed to reduce the health-
related quality of life (HRQoL) of those affected. The
estimation of HRQoL to assess either health status or
the benefit of an intervention is a cornerstone in health
economic evaluation. Quality-adjusted life years (QALYs)
quantify HRQoL and combine the length of life and the
preference weight for a particular health state into a
single measure [8]. The intensity in the preference
weight is measured as a “health utility weight” (HUW).
A HUW of 1.0 indicates “perfect health” while a HUW
of 0.0 represents being dead.
Models have been developed to estimate the cost-
effectiveness of diabetes prevention initiatives which
focus on lifestyle change by calculating the cost per
QALY gained [9]. However, the validity of such models
can be challenged, as not all necessary data are avail-
able. One important gap is information about HUWs
from the same population to allow comparability be-
tween all health states in such models [9]. No prior
research has extracted HUW from NGT, IFG and/or
IGT and T2D from the same source population in a
Swedish population. A recent study in Finland is, ac-
cording to our knowledge, the only investigation that
examined HUWs for NGT, IFG, IGT and T2D [10].
In this study, we aim to estimate and compare HUWs
for individuals with NGT, IFG, IGT and T2D in a Swedish
population, and to evaluate the influence on HUWs of
age, sex, education and body mass index (BMI), factors
known to independently influence HRQoL.
Methods
Study population
Participants of the Västerbotten Intervention Program
(VIP) who underwent an oral glucose tolerance test or
indicated that they had T2D and who filled in the Short
Form-36 questionnaire (SF-36) were included in this
cross-sectional study. As the SF-36 questionnaire was
not included in the VIP before 2003, inclusion in the
study was limited to individuals with examination dates
between January 2003 and February 2012. The VIP was
initiated in 1985 with the aim of reducing morbidity and
mortality from cardiovascular disease and diabetes [11].
All people at ages 40, 50 and 60 living in the Swedish
county of Västerbotten are eligible for inclusion in the
VIP, and are invited to screening and health counseling
conducted by their primary care provider [11]. Thirty-year
olds were also invited until 1996. Part of this screening isan oral glucose tolerance test with a 75 g oral glucose
load conducted according to standards of the World
Health Organization [5]. Based on this test, VIP partic-
ipants were categorized into one of the following glu-
cose groups NGT, IFG, IGT, IFG&IGT, or T2D according
to the 1999 WHO classification [5]. Further, height,
weight, blood pressure and plasma lipids are measured,
and each VIP participant is asked to complete a set of
questionnaires, including questions about physical ac-
tivity, tobacco use and dietary habits. It has been shown
that the participants of VIP are representative of the
county of Västerbotten [12]. The VIP is described in more
detail elsewhere [11].
Health utility weights
The SF-36 is a standardized generic questionnaire com-
prising 36 questions designed to assess self-perceived
health status. It is a psychometric measure that produces
a profile of eight dimensions [13]. The scoring of the
SF-36 is not preference-based and assumes that the
items are of equal importance [14]. The SF-36 has been
reported as valid and reliable in healthy populations and
diabetes patients [15-18]. However, for the estimation of
HUW, preference-based estimates are necessary. There-
fore, the SF-36 must be converted to preference-based
items for the development of the HUW. The Short
Form-6D (SF-6D) questionnaire was developed to obtain
HUWs from the SF-36 questionnaire for use in health
economic evaluations and links between psychometric
and preference/utility-based measures [19]. A subset of
11 questions from the SF-36 is included in the SF-6D
and weighted according to Brazier and Roberts (2004)
[14]. The eight dimensions of the SF-36 were reduced to
six SF-6D dimensions: physical functioning, role limita-
tions, social function, bodily pain, mental health, and
vitality [19]. No limitation in any of the dimensions
means no subtraction from the baseline value of 1.0,
i.e. perfect health. The higher the limitation in each
domain, the higher the subtraction from the baseline
[14]. The summation of the six dimensions constitutes
the HUW. The SF-36 and its conversion to SF-6D for
HUWs are widely used in health economic and epi-
demiological studies [19]. The SF-6D valuation was
shown to be representative for the population of the
United Kingdom [20].
The responses of the SF-36 questionnaires were con-
verted into HUWs using the SF-6D index. For conver-
sion, we used the SAS code “Sf6d_sf36v1_UK_mod.sas”,
obtained from the University of Sheffield [14]. The SF-
36 version 1.0 UK was used in the Swedish language in
the VIP for this analysis. Mean HUW scores were esti-
mated. However, due to the expected asymmetric distri-
bution of the HUWs in the study population, median
HUW scores were also calculated.
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The HUWs were stratified by four potential risk factors
(age, sex, education and BMI), which are known to inde-
pendently influence HUWs and which are easy to meas-
ure. Box plots were used to illustrate stratified HUWs.
Outliers were not displayed, as they would distort the
boxplots. Education was classified as basic (only compul-
sory school or <10 years of formal education), middle
(10–12 years of formal education) or high (university
or ≥13 years of formal education). BMI was classified as
underweight (<18.5), normal weight (18.5-24.9), over-
weight (25.0-29.9) or obese (≥30.0).Statistical analyses
Chi-square tests were conducted to test the significance of
the count data of the description of the study population
(Table 1). The differences of the mean HUWs between the
glucose groups were tested using the Kruskal-Wallis test. To
identify for which glucose groups there were differences, the
post-hoc Mann–Whitney tests with the Bonferroni-Holm
procedure to adjust for multiple comparisons was used [21].Table 1 Study population, total, by age, sex, education and b
Healthy Pre-Diabetes
Characteristics NGT IFG IGT
n % n % n
Total number 43 586 100.0 5 629 100.0 2 440
Age in years
40 15 652 35.9 1 339 23.8 418
50 14 707 33.7 1 846 32.8 706
60 13 227 30.4 2 444 43.4 1 316
Sex
Male 21 076 48.4 2 973 52.8 1 050
Female 22 510 51.7 2 656 47.2 1 390
Education
Basic2 5 655 13.0 1 052 18.7 508
Middle3 22 606 51.9 2 938 52.2 1 275
High4 15 053 34.5 1 596 28.4 634
Missing 272 0.6 43 0.8 23
Body mass index, BMI5
Underweight, <18.5 524 1.2 45 0.8 31
Normal, 18.5 - 24.9 18 917 43.4 1 735 30.8 688
Overweight, 25.0 – 29.9 17 669 40.5 2 420 43.0 1 070
Obesity, ≥30.0 6 293 14.4 1 403 24.9 637
Missing 183 0.5 26 0.5 14
1Chi-square test was used to test for dependencies between glucose tolerance gr
All comparisons were significant (p < 0.001).
2“compulsory school” or “less than 10 years of education in school”.
3“10-12 years of education in school”.
4“university” or “education of more than 12 years in school”.
5BMI = [weight in kg]/[height in m]2.Beta regression as introduced by Ferrari and Cribari-
Neto [22] was used to estimate the effect of multiple risk
factors on the HUW, as the distribution of the HUWs
fitted well with a beta distribution [23]. Beta regression
can be expressed as g μtð Þ ¼
Xk
i¼1
xtiβi which follows the
beta distribution with mean (E(y) = μ) and variance
var yð Þ ¼ μ 1−μð Þ1þϕ
 
where g(.) is the logit link function, xti
represents the t-th observation and βi the unknown re-
gression parameter of the i-th covariate [22]. Beta re-
gression has been applied to analyze HRQoL [24-27]. It
presents the most flexible way to simultaneously esti-
mate the structure of dependence and the distribution
parameters, as the dependent variable is beta distributed.
As covariates were present, the alternative parameterization
with location parameter and scale parameter was used [27].
This is important for the interpretation of the regression
parameters and thus the model equation. The mean HUW
is represented by μ (alternative parameterization). In the
conventional parameterization, the shape parameters need
to be transformed for an equivalent statement.ody mass index1
Diabetes
IFG & IGT T2D Total
% n % n % n %
100.0 1 232 100.0 2 995 100.0 55 882 100.0
17.1 168 13.6 350 11.7 17 927 32.1
28.9 358 29.1 798 26.6 18 415 33.0
53.9 706 57.3 1 847 61.7 19 540 35.0
43.0 638 51.8 1 844 61.6 27 581 49.4
57.0 594 48.2 1 151 38.4 28 301 50.6
20.8 279 22.7 753 25.1 8 247 14.8
52.3 654 53.1 1 568 52.4 29 041 52.0
26.0 286 23.2 639 21.3 18 208 32.6
0.9 13 1.1 35 1.2 386 0.7
1.3 1 0.1 14 0.5 615 1.1
28.2 221 17.9 462 15.4 22 023 39.4
43.9 521 42.3 1 173 39.2 22 853 40.9
26.1 486 39.5 1 320 44.1 10 139 18.1
0.6 3 0.2 26 0.9 252 0.5
oups and age, sex, education level and body mass index respectively.
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tested with the Wald test. The McFadden’s pseudo-R2
was estimated as goodness-of-fit-criterion using the fol-
lowing formula: McFadden’s pseudo-R2 = 1 – ln Lnull/ ln
Lfit, where Lnull is the log-likelihood of the null model,
and Lfit is the log-likelihood of the fitted model [27].
The variable age was used as a continuous variable,
even though only three ages, i.e. 40, 50, 60, were pos-
sible. As the variables education and BMI were ordinal
and not interval scaled, dummy variables were created
to evaluate the differences between basic vs. middle and
basic vs. high education as well as normal weight vs.
underweight, normal weight vs. overweight and normal
weight vs. obese. Basic education and normal weight
were used as reference categories.
Conversion from SF-36 to SF-6D was conducted with
SAS 9.22. For all other statistical analyses STATA/SE
11.0 was used. The significance level for all statistical
tests was 0.05.
Ethical approval for this study was received from the
Regional Ethics Board Dnr 08-131 M at Umeå Univer-
sity, Sweden. All subjects gave informed consent to
future research before their VIP-examination.Results
Study population
The total number of individuals in our analysis was 55 882
(Table 1). The age distribution of study participants was
relatively equally distributed among 40, 50 and 60 year olds
(32.1, 33.0 and 35.0%, respectively), with a mean age of 49,
52, 54, 54 and 55 years among individuals with NGT, IFG,
IGT, IFG&IGT and T2D, respectively. Approximately halfTable 2 SF-6D domains and health utility weights
SF-6D domains
Mean (SD)1 NGT IFG IGT
n 41 208 5 275 2 2
Physical functioning 1.840 (1.12) 2.013 (1.23) 2.2
Role limitations 1.535 (1.26) 1.621 (1.41) 1.7
Social function 2.446 (1.03) 2.491 (1.07) 2.6
Bodily pain 2.416 (1.44) 2.503 (1.46) 2.6
Mental health 1.753 (1.08) 1.767 (1.09) 1.8
Vitality 2.666 (1.19) 2.713 (1.25) 2.7
Health utility weight2
Mean (SD)1 0.768 (0.10) 0.759 (0.11) 0.7
Median 0.793 0.788 0.7
1st-3rd quartile 0.713-0.830 0.681-0.830 0.6
Min-Max3 0.301-0.943 0.334-0.943 0.3
1SD = standard deviation.
2Kruskal-Wallis equality-of-populations rank test, p < 0.001.
3Min-Max = range from minimum to maximum value.(49.4%) of the study population was male. Most study par-
ticipants had middle education (52.0%), followed by high
(32.6%) and basic (14.8%). The majority of the participants
was either overweight (40.9%) or had normal weight
(39.4%) while 18.1% were obese and 1.1% was under-
weight (Table 1). In total, the majority was categorized
as NGT (n = 43 586, 78.0%), while 5 629 individuals
had IFG (10.1%), 2 440 IGT (4.4%), 1 232 IFG&IGT
(2.2%) and 2 995 T2D (5.4%).
People in the older age group tended to have more
severe glucose group (NGT: 30.4% vs. T2D: 61.7% among
60-year olds compared to NGT: 35.9% vs. T2D: 11.7%
among 40-year olds). Further, participants with T2D had
higher BMI (83.3% obese or overweight) comparing par-
ticipants with NGT (54.9% obese or overweight) (Table 1).
All comparisons for dependencies between glucose toler-
ance groups and age, sex, education level and body mass
index respectively were significant (p < 0.001).Health utility weights
The total number of individuals with estimated HUW
was 52 606. There were 3 276 individuals (5.9%) in the
data set which could not contribute to the HUW calcu-
lations (Table 2) due to missing values in the answers of
the SF-36. The overall mean HUW was 0.764. The mean
HUW of healthy individuals was 0.768, 0.759 for those
with IFG, 0.746 for those with IGT, 0.745 for those with
IFG&IGT, and 0.738 for those with T2D. The HUWs de-
pend on the glucose groups (p <0.001). Multiple pairwise
comparisons indicated differences for all glucose groups
besides comparing IGT with T2D, IFG&IGT with T2D
and IGT with IFG&IGT.IFG&IGT T2D Total
61 1 122 2 740 5 2606
45 (1.32) 2.276 (1.34) 2.393 (1.40) 1.914 (1.18)
47 (1.54) 1.825 (1.69) 1.830 (1.58) 1.574 (1.32)
02 (1.23) 2.568 (1.16) 2.606 (1.24) 2.468 (1.06)
68 (1.50) 2.726 (1.52) 2.758 (1.59) 2.460 (1.46)
07 (1.14) 1.836 (1.22) 1.870 (1.27) 1.770 (1.10)
89 (1.28) 2.800 (1.34) 2.860 (1.40) 2.689 (1.22)
46 (0.11) 0.745 (0.11) 0.738 (0.12) 0.764 (0.10)
72 0.772 0.765 0.789
69-0.830 0.667-0.830 0.639-0.830 0.700-0.830
01-0.943 0.383-0.943 0.381-0.943 0.301-0.943
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In all age groups, we observed the highest median HUW
among individuals with NGT, followed by HUWs among
pre-diabetic individuals, and lowest HUWs among indi-
viduals with T2D (Figure 1). Older age was associated
with lower HUW. Women had lower median HUW than
men (Figure 2). We observed a decreasing HUW with
decreasing glucose group, with highest HUW among indi-
viduals with NGT, followed by HUW among individuals
with pre-diabetic states, and lowest among individuals with
T2D. Higher level of education was associated with higher
HUW (Figure 3). BMI was associated with HUW, such
that the higher the BMI, the lower the HUW (Figure 4).
Underweight individuals had almost equivalent HUW as
obese individuals. Underweight individuals with T2D re-
ported lower HUW than obese individuals with T2D.
Multivariate analysis
52 129 individuals were included in the multivariate re-
gression analyses. Among them, 40 857 had NGT, 5 225
had IFG, 2 236 had IGT, 1 113 had IFG&IGT and 2 698
had T2D. The results of the beta regression showed that
all significant factors displayed the same direction, either
positive or negative, regardless of glucose group, except
for age in the IFG&IGT model (Table 3). However, the
McFadden’s pseudo-R2 was low for all models, ranging
from 0.0120 to 0.0349 (Table 3).
Using the results of the multivariate regression (Table 3),
the mean HUWs (Table 2) can be adjusted for specific
sex, age, education and BMI values. For example, theFigure 1 Health utility weights by age and glucose groups.HUW for a women with NGT, aged 40 years with “middle
education” and classified as obese would be estimated as
the following: 1.5568 (constant) - 0.0002 * 40 (age 40) -
0.1940 (female sex) +0.0531 (middle education) - 0.1783
(obese) =1.2296. Using the inverse logit function on the
predicted value 1.2296, one gets exp(1.2296)/(1+ exp
(1.2296)) =0.7737. This result is very close to the observed
mean value for individuals with NGT (0.768).
In the overall model, all but underweight vs. normal
weight were significant factors. Being overweight in com-
parison to normal weight was associated with increased,
whereas being obese was associated with decreased,
HUWs. Younger age, male sex, and higher education
were associated with higher HUW.
The models including those with NGT or IFG only
showed the same pattern as the overall model, except age,
which was not significant in both models. For individuals
with IGT, age and education were not significant. The
model for individuals with IFG&IGT only estimated that an
increasing age lead to increasing HUWs. High vs. basic edu-
cation and overweight vs. normal weight were not signifi-
cantly associated with HUW. Among individuals with T2D,
age, middle vs. basic education, and overweight vs. normal
weight were not significantly associated with HUW. All
other factors were comparable to the overall model.
Discussion
Principal findings
We found that participants with NGT had higher HUWs
than those with T2D, while those with IFG, IGT or a
Figure 2 Health utility weights by sex and glucose groups.
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those for NGT and T2D. All risk factors investigated
were associated with HUW, except underweight vs. nor-
mal weight. Younger age, male sex, and higher education
were associated with increased HUW. Normal weight, or
being overweight was associated with elevated HUW,Figure 3 Health utility weights by education and glucose groups.while obesity was associated with lower HUW. However,
the McFadden’s pseudo-R2 indicated that the model does
not explain much variance. It is recognized by Smithson
and Verkuilen that the McFadden’s pseudo-R2 is often
disappointingly small and may not attain the theoretical
maximum value of one [27]. The McFadden’s pseudo-R2
Figure 4 Health utility weights by BMI and glucose groups.
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linear regressions and different definitions of pseudo R2
can arrive at very different values.
Limitations and strengths
Even though the SF-36 – SF-6D converter has only been
validated for the UK population, it was used here to
draw conclusions about the Swedish population. SF-36
and SF-6D have been widely adopted in Sweden. Still,
the responses to the instruments have not yet been
translated to HUWs for the Swedish population [28].
Any such bias arising from this would apply to all states
and would not influence comparability between states.
Therefore, we judged this converter as appropriate for
describing HUW in this Swedish population. In addition,
our dataset only includes individuals with 40, 50 or
60 years of age. We have, however, used age as continu-
ous instead of categorical variable as we aimed to esti-
mate the effect for all ages in order to make the results
applicable to other settings as well. The extrapolation of
age far from 40 to 60 years is not recommended, as the
variation of estimates will increase according to the
distance from the considered age range 40–60 years. In
addition, our dataset could not distinguish between T2D
cases that were categorized by the oral glucose tolerance
test of VIP compared to those who indicated that they
had T2D at the time of VIP participation.
The VIP is a population-based longitudinal program
from which valid information can be drawn about the
whole population of the county of Västerbotten. Everyeligible man and woman was invited to the program,
thereby minimizing potential selection bias. While no
additional attempt was made to encourage populations
that are hard to reach, no major differences were found
between participants and non-participants in the VIP
[12]. One important strength of this study was the large
number of participants included in the analyses.
Other studies
HUWs measured with SF-6D
The mean overall HUW was 0.764, which is comparable
with results from other studies: the mean baseline
SF-6D HUW of participants in the Diabetes Prevention
Program in the United States was 0.800 [29], while the
HUW calculated for a general Greek population was
0.759 [30]. A study among middle-aged and older Finns
revealed very similar mean health utility values among
individuals with NGT (0.777), IFG (0.771), IGT (0.759)
and newly diagnosed T2D (0.742) [10]. Our estimated
HUW for T2D was 0.738 ranging well in the results of
other studies [10,31,32].
Risk factors
Many studies have also found that older age is associated
with lower HUW [30,33,34]. Sex was the only factor that
was significant in all regression models leading to the con-
clusion that women show lower HUWs than men. This
has been widely reported in the literature [19,30,33-35].
We found that education was a significant predictor of
HUW in some of the models, with lower education being
Table 3 Regression coefficients for health utility weight by age, sex, education, BMI and glucose group, beta regression1
Coefficient (95% CI)2 NGT IFG IGT IFG&IGT T2D Total
Age −0.0002 −0.0011 −0.0013 0.0050 0.0002 −0.0008
(metric) (−0.0008 - 0.0005) (−0.0031 – 0.0008) (−0.0044 – 0.0018) (0.0003 – 0.0095) (−0.0030 – 0.0035) (−0.0014 – -0.0003)
Sex −0.1940 −0.1855 −0.1259 −0.1905 −0.1968 −0.1889
(reference: male) (−0.2048 - -0.1833) (−0.2160 - -0.1549) (−0.1733 - -0.0784) (−0.2558 – -0.1253) (−0.2418 - -0.1519) (−0.1984 - -0.1793)
Education
(reference: basic)3
Middle4 0.0531 0.0571 0.0175 0.1304 0.0489 0.0552
(0.0364 – 0.0697) (0.0158 – 0.0984) (−0.0440 – 0.0791) (0.0470 – 0.2137) (−0.0050 – 0.1029) (0.0411 – 0.0694)
High5 0.0800 0.0645 0.0595 0.0942 0.0675 0.0813





Underweight, <18.5 0.0033 0.0311 0.2074 0.0803 0.2749 0.0202
(−0.0448 – 0.0515) (−0.1404 – 0.2026) (−0.0095 – 0.4244) (−1.0080 – 1.1686) (−0.0711 – 0.6210) (−0.0250 – 0.0654)
Overweight,
25.0 – 29.9
0.0549 0.0570 0.0593 0.0756 0.0359 0.0590
(0.0432 – 0.0665) (0.0212 – 0.0927) (0.0027 – 0.1159) (−0.0170 – 0.1682) (−0.0306 – 0.1023) (−0.0483 – 0.0696)
Obesity, ≥30.0 −0.1783 −0.1892 −0.1288 −0.1858 −0.1721 −0.1929
(−0.1939 – -0.1626) (−0.2291 – -0.1492) (−0.1920 – -0.0656) (−0.2781 – 0.0935) (−0.2368 – -0.1075) (−0.2061 – -0.1798)
Constant 1.5568 1.5158 0.9803 0.9812 0.9028 1.5438
(1.4493 – 1.6642) (1.1467 – 1.8849) (0.5003 – 1.4604) (−1.2147 – 3.1771) (0.1722 – 1.6333) (1.4441 - 1.6435)
n 40 857 5 225 2 236 1 113 2 698 52 129
McFadden’s
pseudo-R2
0.0219 0.0253 0.0120 0.0349 0.0297 0.0238
Significant coefficients are in bold print with significance at a 5% level.
1Wald chi2: all five models are significant, p <0.001.
2CI = confidence interval.
3“compulsory school” or “less than 10 years of education in school”.
4“10-12 years of education in school”.
5“university” or “education of more than 12 years in school”.
6BMI = [weight in kg]/[height in m]2.
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http://www.hqlo.com/content/12/1/150associated with lower HUW, a finding that has been
reported elsewhere [30,33]. Our results confirm those of
previous studies which reported that obesity is associated
with lower HUW [30,33,36]. However, our results contra-
dict with studies indicating that being underweight [36,37]
or overweight decreased HUW [19] compared to normal
weight. In our study, individuals with underweight and
overweight had higher HUW compared to individuals
with normal weight.
Implications for policy makers
We used standardized cost-effectiveness measures for
modeling T2D disease interventions, which allow com-
parison with other published findings and HRQoL of
other diseases [38]. Our results allow conclusions to be
made about the value of preference for a certain state
versus another state enabling cost-effectiveness and
cost-utility estimations using cost per QALY gained. Ourfindings show that early prevention of T2D, i.e. prevent-
ing IFG and IGT, could improve the population’s
HRQoL, as the HRQoL has already diminished once a
person has developed IFG or IGT. The early initiation of
healthy lifestyle interventions is encouraged. Our results
could motivate individuals with pre-diabetes to partici-
pate in prevention initiatives, mainly lifestyle modifica-
tion. Further, policy makers and health care providers
could consider to screen for pre-diabetes and to support
programs to prevent T2D among those with pre-
diabetes.
We encourage further evaluations of HUW instru-
ments for the Swedish population. While we decided to
only consider a small number of predictors for HUWs,
estimations of the influence of other risk factors on
HUWs are needed.
This analysis is part of health economics research to
investigate the cost-effectiveness of diabetes prevention
Neumann et al. Health and Quality of Life Outcomes 2014, 12:150 Page 9 of 10
http://www.hqlo.com/content/12/1/150initiatives. Previous analyses revealed that data was miss-
ing for this broad aim [9], with information on HUWs
lacking for people with T2D, pre-diabetes and NGT from
one source population. Our research adds important in-
formation for a T2D prevention cost-effectiveness model
using cost per QALY gained as measurement.
Conclusions
This is the first study that estimated the HUW for NGT,
IFG, IGT, IFG&IGT and T2D within the Swedish popu-
lation. We found that, depending upon defined risk fac-
tors, the worse the glucose group, the lower the HUWs.
We found that pre-diabetic states decrease the HRQoL
compared to healthy individuals. This shows that, add-
itionally to lowering the risk of developing T2D, prevent-
ing pre-diabetes would also improve the HRQoL. HUWs
can be compared across states that define the natural
history of T2D and allow the establishment of a T2D
prevention model.
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